their normal functions (44) . Asbestos fibers, particularly the highly fibrogenic amphibole types, possess a high iron content that can catalyze the production of hydroxyl radicals through the Haber-Weiss reaction (18) . Schapira et al. (41) provided evidence for this hydroxyl radical formation in rat lungs after asbestos exposure. White blood cells are also a source of ROS (19) , and inhalation of asbestos fibers leads to an intense inflammatory reaction in the lung (6) . Previous studies have shown that asbestos directly increases ROS generation in both human neutrophils (38) and alveolar macrophages (17) . A protective effect has been observed for manganese superoxide dismutase, catalase, and iron chelators such as deferoxamine in various models of asbestos-induced cellular damage (29, 30, 36) . Collectively, these data suggest that an oxidant-antioxidant imbalance is a key event in the pathogenesis of asbestosis.
Extracellular superoxide dismutase (EC-SOD) is a 135-kDa antioxidant enzyme that scavenges the superoxide free radical and is expressed in especially high levels in mammalian lungs. EC-SOD exists primarily as a homotetramer (33) , and each subunit contains a positively charged heparin-binding domain that confers affinity for the extracellular matrix (ECM) (reviewed in Ref. 12 ). This heparin-binding domain can be posttranslationally cleaved without affecting enzyme activity (40) .
EC-SOD has been shown to be protective in several models of interstitial lung injury (5, 13) . However, the role of EC-SOD in models of pneumoconiosis has not been examined. Here we report a redistribution of this antioxidant from the ECM of the lung into the alveolar lining fluid after intratracheal instillation of asbestos due to proteolysis of the heparin-binding domain. Thus proteolytic clearance of EC-SOD from the pulmonary interstitium after acute asbestos injury may contribute to the oxidant-antioxidant imbalances that could then lead to pulmonary fibrosis.
MATERIALS AND METHODS

Materials.
Crocidolite asbestos fibers (Ͼ10 m in length) were obtained from the National Institutes of Environmental Health Sciences. Xanthine oxidase was from Boehringer Mannheim (Indianapolis, IN). Eosin Y, phloxine B, xanthine, equine partially acetylated cytochrome c, Ponceau S, chloramine T, methyl cellosolve, titanium dioxide, and anti-␤-actin antibody were purchased from Sigma (St. Louis, MO). Mayer's hematoxylin, 10% buffered formalin, and pdimethylaminobenzaldehyde were from Fisher Scientific (Pittsburgh, PA). Clear Rite was obtained from Richard-Allan Scientific (Kalamazoo, MI). Nova Red staining kit and ABC immunohistochemistry reagent were from Vector Laboratories (Burlingame, CA). Protein blocking solution was from Immunon (Thermo Shandon, Pittsburgh, PA). Anti-albumin antibody was obtained from ICN (Aurora, OH). Enhanced chemiluminescence detection reagents were purchased from Amersham Biosciences (Buckinghamshire, UK).
Animals. All animal experiments were reviewed and approved by the University of Pittsburgh Institutional Animal Care and Use Committee. Male C57BL/6 mice (Taconic, Germantown, NY), 8 -10 wk old, were treated with 0.1 mg of asbestos, 0.1 mg titanium dioxide, or 0.9% saline vehicle by intratracheal instillation as previously described (1). Mice were euthanized 24 h or 14 days later, as indicated. Bronchoalveolar lavage fluid (BALF) was obtained by the intratracheal instillation and recovery of 0.8 ml 0.9% saline. Lungs were removed and flash frozen in liquid nitrogen and stored at Ϫ70°C until used for biochemical analyses as described below. Lungs from some mice were inflation fixed with 10% buffered formalin and paraffin embedded for histological analysis.
Bronchoalveolar lavage fluid. Total protein was determined by use of the Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL). Total white blood cell counts were obtained with a Beckman Z1 Coulter particle counter (Beckman Coulter, Fullerton, CA). To obtain a differential count, BALF samples were adhered to glass slides with a cytospin, and numbers of macrophages, neutrophils, lymphocytes, and eosinophils were counted under a microscope.
EC-SOD isolation. EC-SOD was isolated and concentrated as previously described (11) . Briefly, lungs were homogenized and sonicated in 50 mM potassium phosphate with 0.3 M potassium bromide, pH 7.4. After an aliquot was removed for Western blotting, the remaining homogenate was passed over a concanavalin A Sepharose column that binds EC-SOD but not other superoxide dismutases. After elution from the column, the separated EC-SOD was concentrated and assayed for superoxide dismutase activity.
EC-SOD activity. EC-SOD activity from lung homogenates was determined as described previously (9) . In this assay, EC-SOD activity was measured by inhibition of the reduction of partially acetylated cytochrome c by superoxide generated by the reaction of xanthine oxidase on xanthine at pH 10.
Western blot analysis. Analysis was performed as previously described (34) . Briefly, 10 g protein from BALF or lung homogenates were subjected to SDS-PAGE and blotted onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). EC-SOD was detected with antibody (1:10,000 dilution) against mouse EC-SOD as previously described (9) . After visualization by enhanced chemiluminescence, densitometry was performed and standardized to mouse ␤-actin or Ponceau S staining with the use of Kodak 1D software (Rochester, NY). Ponceau S staining was performed by immersing blots in a 1% solution of Ponceau S in 5% acetic acid for 10 min followed by rinses in distilled water.
Histology and immunohistochemistry. Standard hematoxylin and eosin staining was performed on 5-m-thick lung sections as previously described (9) . Immunohistochemistry was also performed as previously described with changes noted below (34) . Briefly, slides were deparaffinized and incubated in 6% hydrogen peroxide in methanol to inactivate endogenous peroxidases and then 0.1% pepsin for antigen retrieval. After blocking with protein blocking solution, slides were incubated with the same antibody against mouse EC-SOD (1:500) used in Western blotting or with normal rabbit sera as a control for 60 min. A 30-min incubation in biotinylated secondary antibody (1:1,000) was followed by 30 min in ABC reagent. Slides were developed with the Nova Red staining kit. All slides were stained on the same day and developed for the same amount of time. Photos of 10 random fields from each slide taken at ϫ40 magnification with oil immersion were analyzed for EC-SOD staining intensity by using Metamorph software (Molecular Devices, Sunnyvale, CA) as previously described (34) . We have previously shown that quantification of EC-SOD staining in immunoperoxidase-stained slides using this method produces similar results compared with immunofluorescence staining (34) .
Histological scoring. Hematoxylin and eosin-stained slides were scored by a pathologist blinded to sample groups. Individual fields were examined with a light microscope at high-power (ϫ400) magnification. Every other field was scored in a spiraling pattern beginning peripherally in the lung and ending more centrally until 20 fields were counted for each slide. To be counted, each field had to contain alveolar tissue in Ͼ50% of the field. Scoring in each field was based on the percentage of alveolar tissue with interstitial fibrosis according to the following scale: 0 ϭ no fibrosis, 1 ϭ up to 25%, 2 ϭ 25-50%, 3 ϭ 50 -75%, 4 ϭ 75-100%.
Hydroxyproline assay. Whole lungs were dried and acid hydrolyzed in sealed, oxygen-purged glass ampoules containing 2 ml of 6 N HCl for 24 h at 110°C. Samples were again dried and then resuspended in 1.5 ml phosphate-buffered saline followed by incubation at 60°C for 1 h. Samples were centrifuged at 13,000 rpm, and the supernatant was taken for hydroxyproline analysis by using chloramine-T as previously described (45) .
RESULTS
Intratracheal instillation of asbestos causes lung inflammation.
To assess the acute response of the lung to asbestos, protein and inflammatory cell accumulation in the BALF were determined. Compared with saline-treated controls, asbestostreated mice possessed significantly greater BALF total protein (Table 1 ). In addition, these mice exhibited greater numbers of cells in their BALF. After application of BALF to glass slides with a cytospin, it was revealed that almost all of these cells were leukocytes. The majority of leukocytes were identified as neutrophils. To ensure that the changes observed were not due to a nonspecific response to particles in the lung, the experiments were repeated using titanium dioxide as an inert particulate control (21) . Although the neutrophil counts in titanium dioxide-treated mice were elevated with respect to salinetreated mice, this increase was not significant (P Ͼ 0.05). The number of neutrophils in asbestos-treated mice, however, was significantly greater compared with these titanium dioxidetreated mice. Histological analysis of lung tissue from asbestos-treated mice revealed asbestos fibers along with interstitial thickening and inflammation (Fig. 1) . Collectively, these data indicate that intratracheal instillation of asbestos leads to significant pulmonary damage as well as inflammation dominated by neutrophils 24 h after the injury.
EC-SOD is depleted from the lung parenchyma after asbestos exposure. EC-SOD activity in lung tissue was significantly diminished in asbestos-treated mice compared with controls (Fig. 2) . When EC-SOD protein abundance was compared by Western blotting, lung homogenates from mice treated with asbestos had significantly decreased EC-SOD compared with both saline-and titanium dioxide-treated controls (Fig. 3) . Coincident with this depletion from the lung was a significant increase in BALF levels of EC-SOD in asbestos-treated mice compared with saline-treated controls (Fig. 4A) . This increase was also present when BALF levels of EC-SOD were normalized to total protein loading as determined by Ponceau S staining of Western blots (data not shown). In the BALF, there was an increased ratio of cut to uncut EC-SOD in the asbestos mice compared with controls, indicating increased proteolysis of EC-SOD (Fig. 4B) . Similar results were obtained when titanium dioxide was used as a control instead of saline alone (not illustrated). Because proteolysis of EC-SOD removes the heparin-binding domain that confers affinity for the ECM, proteolysis may therefore lead to a redistribution of EC-SOD from lung parenchyma into the air spaces.
Immunohistochemistry for EC-SOD confirmed our Western blot and EC-SOD activity results. Quantification of EC-SOD labeling revealed strong staining intensity for EC-SOD in the alveolar septa of saline-treated mice, matching data our laboratory has previously published (11, 34) . In contrast, the septa of asbestos-treated mice had significantly decreased staining intensity, indicating a loss of EC-SOD from these areas (Fig. 5) .
Redistribution of EC-SOD in the lung is associated with development of pulmonary fibrosis.
To determine whether redistribution of EC-SOD correlates with the development of pulmonary fibrosis in response to asbestos (asbestosis), we examined mice 14 days after a single intratracheal instillation of either titanium dioxide or asbestos (0.1 mg). BALF protein and white blood cell counts were slightly attenuated in asbestos-treated mice at 14 days compared with asbestos-treated mice at 24 h (Table 1) . However, levels of both of these parameters were significantly increased over 14-day titanium dioxide-treated control mice. EC-SOD Western blots also revealed greater amounts of EC-SOD in the BALF of asbestostreated mice compared with controls ( Fig. 6 ), indicating that EC-SOD continued to accumulate in the BALF 14 days after exposure to asbestos. Histological analysis was performed on these mice to determine whether fibrosis developed 14 days after exposure to asbestos. As shown in Fig. 7 , asbestos-treated mice possessed increased pulmonary fibrosis compared with titanium dioxide controls. Hydroxyproline levels were also measured to quantitate fibrosis and revealed significantly greater collagen deposition in asbestos-treated mice over controls (Fig. 8) . Fig. 3 . Asbestos decreases total EC-SOD protein in the lung. Western blot analysis was performed using 5 g of total lung protein [n ϭ 4 for saline and titanium dioxide (TiO2), n ϭ 5 for asbestos]. Densitometry was normalized to ␤-actin as a loading control. Error bars denote SE. *P Ͻ 0.05, ANOVA followed by Tukey's posttest. 
DISCUSSION
Asbestos-associated lung diseases are a significant health problem. The ϳ30 million tons of asbestos that have been used in the United States since 1900 have led to both occupational and nonoccupational exposures to these toxic fibers. Although the use of asbestos has been declining in the United States, the long latency between exposure and development of disease ensures that a number of new cases will continue to arise (reviewed in Ref. 23 ).
An oxidant-antioxidant imbalance is theorized to underlie the pathogenesis of asbestos-mediated lung disease. Asbestos exposure in vitro and in vivo leads to ROS formation detectable through markers of oxidative stress (16, 26) . Asbestos also upregulates antioxidants such as manganese superoxide dismutase and glutathione peroxidase, signifying a compensatory response to oxidative stress (20) .
Evidence from our laboratory and others implicates EC-SOD in fibrotic and acute lung injuries. In a bleomycin model of pulmonary fibrosis, we have reported a decrease in EC-SOD protein levels in the lung ECM. This is associated with an increase in the proteolyzed form of EC-SOD lacking the heparin-binding domain in both the lung and BALF (9) . Depletion of EC-SOD from lung ECM was also found in a hyperoxic model of acute lung injury (34) . These results suggest that increased proteolysis of EC-SOD leads to its removal from the lung parenchyma, perhaps leading to increased oxidative stress in the ECM. In support of a protective role for EC-SOD against lung injury, transgenic overexpression of EC-SOD (4) or treatment with superoxide dismutase mimetics (35) protects against bleomycin-induced pulmonary fibrosis, whereas EC-SOD knockouts are more susceptible (8) . In this report, we test the hypothesis that asbestos exposure leads to a loss of EC-SOD from the lung parenchyma that can lead to increased oxidative stress in the lungs. In our mouse model, we observed that asbestos initiates an early inflammatory, primarily neutrophilic, response with associated protein accumulation in the air spaces 24 h after exposure. This confirms results from Dorger et al. (6) , who also found a neutrophilic influx at 24 h in rats after intratracheal instillation of asbestos. Lung histology revealed an influx of leukocytes as well as some interstitial thickening in areas infiltrated by asbestos fibers.
Coincident with this acute inflammation, we observed a depletion of EC-SOD from lung parenchyma by activity assays, immunohistochemistry, and Western blot analysis. In an attempt to localize EC-SOD, we examined the air spaces through BALF recovery. In the BALF, we found an accumulation of proteolyzed EC-SOD. This finding suggests that full-length EC-SOD is being proteolyzed and released from the ECM of the lung in response to asbestos-induced lung injury. The EC-SOD then accumulates in the air spaces, resulting in high amounts of proteolyzed EC-SOD in the BALF. This redistribution of EC-SOD was associated with the development of fibrosis 14 days after initial exposure to asbestos. This redistribution of EC-SOD may leave the lung parenchyma vulnerable to oxidative stress and promote the development of fibrotic injury.
The exact protease cleaving the heparin-binding domain of EC-SOD in our model is currently unknown, but a number of candidates are suggested by other investigations as well as the data presented here. Recent studies have implicated a role for furin in intracellular proteolysis of EC-SOD before secretion into the ECM (3, 7). Neutrophils also possess numerous proteases that may be released during the pulmonary inflammation accompanying asbestos exposure. In addition, asbestos fibers lead to extensive cytotoxicity (25) , particularly in epithelial cells (2) and macrophages (15) . These dying cells may release proteases into the ECM. Finally, asbestos exposure leads to increased vascular permeability and edema (6) , which may introduce proteolytic enzymes from the circulation into the lung. Future studies will examine these possibilities in greater detail.
Although we have observed similar results in other inflammatory models of lung injury, it remains to be determined whether EC-SOD depletion from the lung contributes to inflammation or is a by-product of increased inflammation and release of proteolytic factors. We hypothesize that loss of EC-SOD can be proinflammatory. Collagen is one potential target of oxidative stress in asbestos lung injury and is present in high amounts in the ECM. Collagen fragments are known chemoattractants and activators of neutrophils (28) . It has been shown that latent collagenases can be activated by ROS (14, 39) and that collagen itself can be directly fragmented by oxidative stress (43) . EC-SOD has been shown to associate with type I collagen (32) and can prevent its oxidative fragmentation in vitro (37) and in vivo (8) . Depletion of EC-SOD from the lung parenchyma could lead to increased collagen fragmentation and increased neutrophil chemotaxis and activation. It has already been shown that EC-SOD can inhibit pulmonary inflammation in response to hyperoxia (13) and bleomycin (8) . In further support of this hypothesis, we find that neutrophil immigration into the lung coincides with loss of EC-SOD from the lung in asbestos-treated mice (Table 1; Figs. 2, 3, 4A, 5). Neutrophils themselves can also produce large quantities of ROS (which can lead to more collagen fragmentation) and proteases (which can cleave collagen and can also potentially cleave the heparin-binding domain of EC-SOD, leading to its release from the lung parenchyma).
In summary, we report that a redistribution of pulmonary EC-SOD occurs 24 h after intratracheal instillation of asbestos. EC-SOD appears to be proteolytically removed from lung parenchyma with subsequent accumulation in the air spaces. The loss of this antioxidant from lung parenchyma may increase vulnerability of the lung parenchyma to oxidative stress. This change in localization of EC-SOD may contribute to the oxidant-antioxidant imbalance that contributes to asbestosinduced injury and may be a key early event in the progression to asbestosis and other asbestos-mediated diseases.
